DNA Damage in Arsenite- and Cadmium-treated Bovine Aortic Endothelial Cells
Overview
Biology
General Medicine
Affiliations
Reactive oxygen species have been shown to be involved in the mutagenicity, clastogenicity, and apoptosis of mammalian cells treated with arsenic or cadmium. As these endpoints require several hours of cellular processing, it is not clear that reactive oxygen species damage DNA directly or interfere with DNA replication and repair. Using single-cell alkaline electrophoresis, we have detected DNA strand breaks (DSBs) in bovine aortic endothelial cells by a 4-h treatment with sodium arsenite (As) and cadmium chloride (Cd) in sublethal concentrations. As-induced DSBs could be decreased by nitric oxide (NO) synthase inhibitors, superoxide scavengers, and peroxynitrite scavengers and could be increased by superoxide generators and NO generators. Treatment with As also increased nitrite production. These results suggest that As-increased NO may react with O2*- to produce peroxynitrite and cause DNA damage. The results showing that Cd increased cellular H2O2 levels and that Cd-induced DSBs could be modulated by various oxidant modulators suggest that Cd may induce DSBs via O2*-, H2O2, and *OH. Nevertheless, the DSBs in both As- and Cd-treated cells seem to come from the excision of oxidized bases such as formamidopyrimidine and 8-oxoguanine, as the Escherichia coli enzyme formamidopyrimidine-DNA glycosylase (Fpg) increased DSBs in cells treated with As, 3-morpholinosydnonimine (a peroxynitrite-generating agent), Cd, or H2O2.
Role of curcumin in ameliorating hypertension and associated conditions: a mechanistic insight.
Joshi P, Joshi S, Semwal D, Verma K, Dwivedi J, Sharma S Mol Cell Biochem. 2022; 477(10):2359-2385.
PMID: 35569080 DOI: 10.1007/s11010-022-04447-8.
Migliaccio S, Bimonte V, Besharat Z, Sabato C, Lenzi A, Crescioli C Biomolecules. 2022; 12(1).
PMID: 35053192 PMC: 8773563. DOI: 10.3390/biom12010044.
Wen X, Kozlosky D, Zhang R, Doherty C, Buckley B, Barrett E Drug Metab Dispos. 2021; 49(8):629-637.
PMID: 34074729 PMC: 8382159. DOI: 10.1124/dmd.121.000446.
Ruslee S, Zaid S, Bakrin I, Goh Y, Mustapha N BMC Complement Med Ther. 2020; 20(1):160.
PMID: 32471398 PMC: 7260854. DOI: 10.1186/s12906-020-02960-1.
Nasiadek M, Danilewicz M, Klimczak M, Stragierowicz J, Kilanowicz A Oxid Med Cell Longev. 2020; 2019:6490820.
PMID: 31949881 PMC: 6935823. DOI: 10.1155/2019/6490820.